Da traduttori professionisti, imprese, pagine web e archivi di traduzione disponibili gratuitamente al pubblico.
retroviral γc cdna containing vector
retroviral γc cdna containing vector
Ultimo aggiornamento 2011-10-23
Frequenza di utilizzo: 1
Qualità:
Attenzione: Questo allineamento potrebbe essere errato.
Eliminalo se ritieni che sia così.
& annullérall collections containing recipients.
& Ακύρωσηall collections containing recipients.
Ultimo aggiornamento 2011-10-23
Frequenza di utilizzo: 1
Qualità:
Attenzione: contiene formattazione HTML nascosta
& annullérall collections containing recipients.
& ÎκÏÏÏÏηall collections containing recipients.
Ultimo aggiornamento 2011-10-23
Frequenza di utilizzo: 1
Qualità:
Attenzione: contiene formattazione HTML nascosta
forbindelseshemmeligheder@ title: tab tab containing menu tooltip settings
Σύνδεση@ title: tab tab containing menu tooltip settings
Ultimo aggiornamento 2011-10-23
Frequenza di utilizzo: 1
Qualità:
802. 1x@ title: tab tab containing general ui settings
@ title: tab tab containing general ui settings
Ultimo aggiornamento 2011-10-23
Frequenza di utilizzo: 1
Qualità:
arkivering@ title: column column containing message subjects
Λήψη@ title: column column containing message subjects
Ultimo aggiornamento 2011-10-23
Frequenza di utilizzo: 1
Qualità:
bruger- id@ title: column column containing email addresses
id χρήστη@ title: column column containing email addresses
Ultimo aggiornamento 2011-10-23
Frequenza di utilizzo: 1
Qualità:
spc for antimicrobial products demonstration of efficacy for veterinary medicinal products containing antimicrobial subsatnces
demonstration of efficacy for veterinary medicinal products containing antimicrobial subsatnces
Ultimo aggiornamento 2011-10-23
Frequenza di utilizzo: 1
Qualità:
Attenzione: Questo allineamento potrebbe essere errato.
Eliminalo se ritieni che sia così.
guidelines position paper on the risks associated with the use of herbal products containing aristolochia species
the use of herbal products containing
Ultimo aggiornamento 2011-10-23
Frequenza di utilizzo: 1
Qualità:
Attenzione: Questo allineamento potrebbe essere errato.
Eliminalo se ritieni che sia così.
note for guidance on comparability of medicinal products containing biotechnology- derived proteins as active substances
biotechnology- derived proteins as active substances position statement on the use of tumorigenic cells of human origin for the
Ultimo aggiornamento 2011-10-23
Frequenza di utilizzo: 1
Qualità:
Attenzione: Questo allineamento potrebbe essere errato.
Eliminalo se ritieni che sia così.
points to consider on quality aspects of medicinal products containing active substances produced by stable transgene experession in higher plants
points to consider on quality aspects of medicinal products containing active substances produced by stable transgene experession in higher plants
Ultimo aggiornamento 2011-10-23
Frequenza di utilizzo: 1
Qualità:
Attenzione: Questo allineamento potrebbe essere errato.
Eliminalo se ritieni che sia così.
to prove that a notice has been sent , it shall be sufficient to prove that the notice was delivered to the relevant address or that the envelope containing such notice was properly addressed and posted .
to prove that a notice has been sent , it shall be sufficient to prove that the notice was delivered to the relevant address or that the envelope containing such notice was properly addressed and posted .
Ultimo aggiornamento 2011-10-23
Frequenza di utilizzo: 1
Qualità:
titel på dokumentet note for guidance on the use of bovine serum in the manufacture of human biological medicinal products points to consider on quality aspects of medicinal products containing active substances produced by stable transgene expression in higher plants revision of note for guidance on minimising the risks of tse transmission via medicinal products points to consider on the development of live attenuated influenza vaccines
Τίτλος εγγράφου note for guidance on the use of bovine serum in the manufacture of human biological medicinal products points to consider on quality aspects of medicinal products containing active substances produced by stable transgene expression in higher plants revision of note for guidance on minimising the risks of tse transmission via medicinal products points to consider on the development of live attenuated influenza vaccines
Ultimo aggiornamento 2011-10-23
Frequenza di utilizzo: 1
Qualità:
Attenzione: Questo allineamento potrebbe essere errato.
Eliminalo se ritieni che sia così.
63) note for guidance on photosafety testing points to consider document on the need for assessment of reproductive toxicity of human insulin analogues discussion paper on environmental risk assessments of non- gmo containing medicinal products for human use non- clinical documentation of medicinal products with ‘ well- established use ’ note for guidance on the need for non- clinical testing of pharmaceuticals in juvenile animals discussion paper on the non- clinical safety studies to support single low dose clinical screening studies in man note for guidance on specification limits for residues for heavy metal catalysts in medicinal products points to consider on xenogeneic cell therapy note for guidance on comparability of biotechnology products pre- clinical and clinical issues points to consider on the assessment of the potential for qt interval prolongation by non- cardiovascular medicinal products note for guidance on risk assessment of medicinal products on human reproductive and development toxicities: from data to labelling
63) note for guidance on photosafety testing points to consider document on the need for assessment of reproductive toxicity of human insulin analogues discussion paper on environmental risk assessments of non- gmo containing medicinal products for human use non- clinical documentation of medicinal products with ‘ well- established use ’ note for guidance on the need for non- clinical testing of pharmaceuticals in juvenile animals discussion paper on the non- clinical safety studies to support single low dose clinical screening studies in man note for guidance on specification limits for residues for heavy metal catalysts in medicinal products points to consider on xenogeneic cell therapy note for guidance on comparability of biotechnology products pre- clinical and clinical issues points to consider on the assessment of the potential for qt interval prolongation by non- cardiovascular medicinal products note for guidance on risk assessment of medicinal products on human reproductive and development toxicities: from data to labelling
Ultimo aggiornamento 2011-10-23
Frequenza di utilizzo: 1
Qualità:
Attenzione: Questo allineamento potrebbe essere errato.
Eliminalo se ritieni che sia così.